Sort
21,281 grants matching “influenza”
Basal cells in airway and alveolar remodeling
$592,860Barry R Stripp · Cedars-Sinai Medical Center · R01 · FY2024 · HL
Risk of Influenza Infection In A Vaccinated Obese Population
$592,709Melinda A. Beck · Univ Of North Carolina Chapel Hill · R01 · FY2012 · AI
Designing T-cell Based HIV Vaccines using Peptide-MHC Surface Morphology
$592,665Ha Youn Lee · University Of Southern California · R01 · FY2015 · AI
Acquisition of a Luxendo MuVi Light Sheet Microscope for the University of Rochester Light Microscopy Shared Resource Laboratories
$592,568Verda Kaye Thomas · University Of Rochester · S10 · FY2022 · OD
REPLICATION OF INFLUENZA VIRUS
$592,507Robert M Krug · University Of Texas At Austin · R01 · FY2006 · AI
Vanderbilt Vaccine and Treatment Evaluation Unit
$592,422Clarence Buddy Creech · Vanderbilt University Medical Center · UM1 · FY2022 · AI
Mechanisms of dysregulated immunity with aging
$592,344Daniel Robert Goldstein · University Of Michigan At Ann Arbor · R01 · FY2020 · AG
Defining molecular mechanisms of combination adjuvants: a systems immunology, transcriptomics and imaging approach
$592,289David Huw Davies · University Of California-Irvine · U01 · FY2023 · AI
Role of B Lymphocytes In HIV Infection And Pathogenesis
$592,109Anthony S. Fauci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Excellence in Research for Emerging and Reemerging Diseases of Public Health Interest in Colombia at the National Institute of Health
$592,000Martha Ospina · Colombian National Institute Of Health · U01 · FY2020 · GH
A combined computational and experimental approach to the evolution and role of the DNA sequence environment in targeting mutations to antibody V regions
$591,815Matthew D Scharff · Albert Einstein College Of Medicine · R01 · FY2020 · AI
Developmental immunotoxicity of PFAS
$591,809B. Paige Lawrence · University Of Rochester · R01 · FY2024 · ES
Systems Immunogenetics of Influenza Virus Infection in the Collaborative Cross
$591,594Mark T Heise · Univ Of North Carolina Chapel Hill · U19 · FY2017 · AI
Impact of a Community Care Intervention to Address Inequities in COVID-19 and Influenza Vaccination Among Adults Suffering from Disproportionate Chronic Disease
$591,567Marielena Lara · Rand Corporation · R01 · FY2024 · MD
Developmental immunotoxicity of PFAS
$591,295B. Paige Lawrence · University Of Rochester · R01 · FY2025 · ES
Animal Models Core
$591,188Fernando Pardo-Manuel De Villena · Univ Of North Carolina Chapel Hill · U19 · FY2012 · AI
Novel immunotherapeutics for the management of otitis media due to H. influenzae
$591,017Lauren O Bakaletz · Research Inst Nationwide Children'S Hosp · R01 · FY2019 · DC
Pediatric Immune Correlates of Early Anti-HIV Therapy
$590,873Luis J. Montaner · Wistar Institute · R01 · FY2007 · AI
Developing a Rapid, Simple-to-use Sensory Platform for Detection of Ultralow Concentration of SARS-CoV-2 Viral Particles Enabled by Electrophoretic Enhancement and Redox Cycling
$590,800Seyedehaida Ebrahimi · Pennsylvania State University, The · R21 · FY2021 · EB
KSHV, HIV and the Kaposi's Sarcoma Tumor Niche
$590,775John T. West · University Of Nebraska Lincoln · R01 · FY2020 · CA
Genetic, Social, and Developmental Epidemiology of Drug Use Disorders
$590,694Kenneth Seedman Kendler · Virginia Commonwealth University · R01 · FY2023 · DA
Virulence Determinants in Staphylococcus Bacteremia
$590,590Steven R. Gill · University Of Rochester · R01 · FY2011 · AI
Salmonella anti-influenza DNA & antigen delivery vaccine
$590,554Roy Curtiss · Arizona State University-Tempe Campus · R01 · FY2008 · AI
Complement Receptors in Humoral Immunity to Influenza
$590,527Michael Craig Carroll · Harvard Medical School · P01 · FY2011 · AI
RAPID VACCINATION OF HARD TO REACH POPULATI0NS
$590,307New York Academy Of Medicine · R01 · FY2003 · DA